Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ilana G. Dzuba
Observed names:
I Dzuba,
I G Dzuba,
I. Dzuba,
I. G. Dzuba,
I.G. Dzuba,
Ilana Dzuba,
Ilana G Dzuba
show all 7
Institutions:
Brigham and Women's Hospital,
Harvard University,
Ariadne Labs
Observed institutions:
Brigham and Women's Hospital,
EngenderHealth,
Harvard University,
Johns Hopkins University,
Mexican Social Security Institute,
Gynuity Health Projects,
Instituto Nacional de Salud Pública,
Ariadne Labs
show all 8
OpenAlex ID:
A5018285680
Works
40
Awards
1
The Acceptability of Self-Collected Samples for HPV Testing vs. the Pap Test as Alternatives in Cervical Cancer Screening
2002
·
Ilana G. Dzuba
, Elsa Yunes Díaz
, et al.
·
Journal of Women s Health & Gender-Based Medicine
·
226
Factors affecting utilization of cervical cancer prevention services in low-resource settings
2003
·
Allison Bingham
, Amie Bishop
, et al.
·
Salud Pública de México
·
186
PDF
Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women receiving prophylactic oxytocin: a double-blind, randomised, non-inferiority trial
2010
·
Jennifer Blum
, Beverly Winikoff
, et al.
·
The Lancet
·
144
Extending Outpatient Medical Abortion Services Through 70 Days of Gestational Age
2012
·
Beverly Winikoff
, Ilana G. Dzuba
, et al.
·
Obstetrics and Gynecology
·
116
Two Distinct Oral Routes of Misoprostol in Mifepristone Medical Abortion: A Randomized Controlled Trial
2008
·
Beverly Winikoff
, Ilana G. Dzuba
, et al.
·
Obstetrics and Gynecology
·
116
Medical abortion: A path to safe, high-quality abortion care in Latin America and the Caribbean
2013
·
Ilana G. Dzuba
, Beverly Winikoff
, et al.
·
The European Journal of Contraception & Reproductive Health Care
·
78
Involving the community in cervical cancer prevention programs
2005
·
I. Agurto
, S. Arrossi
, et al.
·
International Journal of Gynecology & Obstetrics
·
71
A strategic assessment of cervical cancer prevention and treatment services in 3 districts of Uttar Pradesh, India
2005
·
Rasha Dabash
, Jyoti Vajpayee
, et al.
·
Reproductive Health
·
59
PDF
Safety, efficacy and acceptability of outpatient mifepristone-misoprostol medical abortion through 70 days since last menstrual period in public sector facilities in Mexico City
2014
·
Patricio Sanhueza Smith
, Melanie Peña
, et al.
·
Reproductive Health Matters
·
51
Intramuscular injection, intravenous infusion, and intravenous bolus of oxytocin in the third stage of labor for prevention of postpartum hemorrhage: a three-arm randomized control trial
2019
·
Dyanna Charles
, Holly Anger
, et al.
·
BMC Pregnancy and Childbirth
·
47
PDF
A non-inferiority study of outpatient mifepristone-misoprostol medical abortion at 64–70 days and 71–77 days of gestation
2020
·
Ilana G. Dzuba
, Erica Chong
, et al.
·
Contraception
·
42
Advocating for cervical cancer prevention
2005
·
J. Sherris
, I. Agurto
, et al.
·
International Journal of Gynecology & Obstetrics
·
41
Women's Perspectives on Cervical Screening and Treatment in Developing Countries: Experiences with New Technologies and Service Delivery Strategies
2006
·
Janet Bradley
, Patricia Coffey
, et al.
·
Women & Health
·
39
A participatory assessment to identify strategies for improved cervical cancer prevention and treatment in Bolivia
2005
·
Ilana G. Dzuba
, Ruth Calderón
, et al.
·
Revista Panamericana de Salud Pública
·
33
PDF
A repeat dose of misoprostol 800 mcg following mifepristone for outpatient medical abortion at 64–70 and 71–77 days of gestation: A retrospective chart review
2020
·
Ilana G. Dzuba
, Philicia W. Castillo
, et al.
·
Contraception
·
28
Does route matter? Impact of route of oxytocin administration on postpartum bleeding: A double-blind, randomized controlled trial
2019
·
Jill Durocher
, Ilana G. Dzuba
, et al.
·
PLoS ONE
·
23
PDF
Early abortion with buccal versus sublingual misoprostol alone: a multicenter, randomized trial
2019
·
Wendy R. Sheldon
, Jill Durocher
, et al.
·
Contraception
·
23
The case for investing in cervical cancer prevention
2004
·
Silvina Arrossi
, Jacqueline Sherris
, et al.
·
23
Efficacy and acceptability of a mifepristone–misoprostol combined regimen for early induced abortion among women in Mexico City
2014
·
Melanie Peña
, Ilana G. Dzuba
, et al.
·
International Journal of Gynecology & Obstetrics
·
22
Medical Abortion: Outcomes in a Family Medicine Setting
2010
·
L. Prine
, C. Shannon
, et al.
·
The Journal of the American Board of Family Medicine
·
16
PDF
Treatment of Postpartum Hemorrhage With Sublingual Misoprostol Versus Oxytocin in Women Receiving Prophylactic Oxytocin: A Double-blind, Randomized, Noninferiority Trial
2011
·
J. Blum
, B. Winikoff
, et al.
·
Obstetric Anesthesia Digest
·
14
A Proof-of-Concept Study of Ulipristal Acetate for Early Medication Abortion
2025
·
Beverly Winikoff
, Manuel Bousiéguez
, et al.
·
NEJM Evidence
·
11
High fever after sublingual administration of misoprostol for treatment of post‐partum haemorrhage: a hospital‐based, prospective observational study in Argentina
2020
·
Jill Durocher
, Jesus Daniel Aguirre
, et al.
·
Tropical Medicine & International Health
·
11
PDF
O207 Route of Administration of Oxytocin in Prevention of Postpartum Hemorrhage
2012
·
I. Dzuba
, J. Durocher
, et al.
·
International Journal of Gynecology & Obstetrics
·
7
Buccal vs. sublingual misoprostol alone for early pregnancy termination in two Latin American settings: a randomized trial
2017
·
W.R. Sheldon
, J. Durocher
, et al.
·
Contraception
·
5
Show more works
View as search
Works count:
40
Citation count:
1,454
H-index:
19
I10-index:
23
Year
Topic
Type